Skip to main content
Clinical Trials/JPRN-UMIN000029947
JPRN-UMIN000029947
Completed
Phase 3

A randomized control trial of conditioning regimen of cord blood transplantation for adult myeloid malignancies comparing CA/CY/TBI with vs without G-CSF priming - CBT-P3 study comparing CA/CY/TBI with vs without G-CSF priming

Japan Agency for Medical Research and Development0 sites160 target enrollmentFebruary 1, 2018

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Myelogenous Hematological Malignancies
Sponsor
Japan Agency for Medical Research and Development
Enrollment
160
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 1, 2018
End Date
December 31, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.HBs antigen positive 2\.HCV antibody positive 3\.HIV antibody positive 4 Donor\-specific anti\-HLA antibody positive 5\.Use of gemtuzumab ozogamicin within 6 months before transplantation 6\.During pregnant or breast\-feeding 7\. Uncontrollable psychiatric disorder 8\. Uncontrollable infection 9\. Allergy for any drug used in the conditioning regimen or GVHD\-prophylaxis 10\.Considered to be unfit for the study enrollment by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials